Sarepta Therapeutics Inc Earnings

The next earnings date for Sarepta Therapeutics Inc is October 29, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Sarepta Therapeutics Inc Earnings

Report DateEstimated Earnings Per Share
10/29/2025$-0.60

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Sarepta Therapeutics Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
07/31/2025---$0-100.00%
07/30/2025---$0-100.00%
04/29/2025Before Market$-3.42-426.64%
02/26/2025Before Market$1.90-7.78%
11/06/2024After Market$0.34361.54%
08/07/2024After Market$0.07600.00%
05/01/2024After Market$0.37628.57%
02/28/2024After Market$0.474,600.00%
11/01/2023After Market$-0.4662.60%
08/02/2023After Market$-0.2784.83%
05/02/2023After Market$-5.86-324.64%
02/28/2023After Market$-1.248.15%
11/02/2022After Market$-2.94-105.59%
08/02/2022After Market$-2.65-124.58%
05/04/2022After Market$-1.205.51%
03/01/2022After Market$-1.42-25.66%
11/03/2021After Market$-0.1989.95%
08/04/2021After Market$-2.30-79.69%
05/05/2021After Market$-2.10-20.69%
03/01/2021After Market$-2.40-34.83%
11/05/2020After Market$-1.93-17.68%
08/05/2020After Market$-1.93-14.88%
05/06/2020After Market$-0.2387.77%
02/26/2020After Market$-3.16-69.89%
11/07/2019After Market$-1.70-25.93%
08/07/2019After Market$-1.39-1.46%
05/08/2019After Market$-1.0737.06%
02/27/2019After Market$-2.05-100.98%
10/24/2018After Market$-1.15-41.98%
08/08/2018After Market$-1.67-87.64%
05/03/2018After Market$-0.55-83.33%
03/01/2018After Market$-0.37-15.63%
10/25/2017After Market$-0.7610.59%
07/19/2017After Market$-0.4649.45%
04/27/2017After Market$-0.71-121.88%
02/28/2017After Market$-0.8734.59%
10/27/2016Before Market$-1.1810.61%
07/19/2016After Market$-1.35-13.45%
05/05/2016Before Market$-1.31-2.34%
02/25/2016After Market$-1.44-22.03%
11/05/2015Before Market$-1.25-5.93%
08/06/2015Before Market$-1.0116.53%
05/07/2015Before Market$-1.49-49.00%
02/26/2015Before Market$-1.08-31.71%
11/06/2014Before Market$-0.7126.04%
08/07/2014---$-0.85-11.84%
05/08/2014---$-0.756.25%
02/27/2014---$-0.2366.67%
11/12/2013---$-1.24-90.77%
08/08/2013---$-0.601.64%
05/09/2013---$-1.32-112.90%
03/07/2013---$-2.36-713.79%
11/07/2012---$-0.30-7.14%
08/07/2012---$0.35266.67%
05/10/2012---$-0.78-77.27%
03/01/2012---$-0.0681.82%
11/03/2011---$-0.1848.57%
08/04/2011---$0.06115.00%
05/05/2011---$0.12163.16%
03/10/2011---$-0.420.00%
11/09/2010---$-0.42-16.67%
08/09/2010---$-0.90-200.00%
05/10/2010---$-0.0677.78%
03/16/2010---$0.18166.67%
11/09/2009---$-0.48-23.08%
08/10/2009---$-1.38-1,050.00%
05/11/2009---$-0.0677.78%
03/10/2009---$-0.0683.33%
11/10/2008---$-0.48-23.08%
08/11/2008---$-0.1273.33%
05/12/2008---$-1.38-206.67%
03/12/2008---$-0.4212.50%
11/06/2007---$-0.78-8.33%
08/08/2007---$-0.96-28.00%
05/09/2007---$-1.08-38.46%
03/15/2007---$-0.96-14.29%
11/08/2006---$-0.787.14%
08/08/2006---$-0.78-18.18%
05/05/2006---$-1.08-200.00%
03/08/2006---$-0.604.76%
11/04/2005---$-0.2468.42%
08/08/2005---$-0.665.71%
05/09/2005---$-0.78-8.33%
03/08/2005---$-0.843.45%
11/04/2004---$-0.840.00%
08/05/2004---$-1.202.44%
05/05/2004---$-1.26-50.00%
03/09/2004---$-1.26-43.18%
11/04/2003---$-0.90-12.50%
08/05/2003---$-0.720.00%
05/06/2003---$-0.7821.21%
03/11/2003---$-0.9030.23%
11/05/2002---$-1.60---
08/06/2002---$-1.80-66.67%
05/07/2002---$-1.98-94.12%
03/12/2002---$-1.20-5.26%
11/12/2001---$-4.05---
06/30/2001---$-0.98---
03/31/2001---$-0.89---
12/31/2000---$-0.96---
09/30/2000---$-0.67---
06/30/2000---$-1.02---
03/31/2000---$-0.42---
09/30/1999---$-0.99---
06/30/1999---$-0.90---
03/31/1999---$-0.78---
09/30/1998---$-11.05---
06/30/1998---$-0.89---
03/31/1998---$-0.77---

More About Sarepta Therapeutics Inc

Website
https://www.sarepta.com
Country
USA
Full Time Employees
1,372

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat Duchenne muscular dystrophy (Duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an adeno-associated virus based gene therapy for the treatment of ambulatory pediatric patients with Duchenne with a confirmed mutation in the Duchenne gene. The company is also developing SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Catalent Maryland, Inc.; Nationwide Children's Hospital; Dyno Therapeutics; Hansa Biopharma; Duke University; and Genethon. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

“Sarepta Therapeutics Inc Earnings” Can Refer to the Sarepta Therapeutics Inc Earnings Date

Some people say “Sarepta Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Sarepta Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Sarepta Therapeutics Inc Stock on the Earnings Date

If you own Sarepta Therapeutics Inc stock (SRPT) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Sarepta Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Sarepta Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Owning Sarepta Therapeutics Inc Options on the Earnings Date

If you own Sarepta Therapeutics Inc options on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

In addition, the extrinsic values of Sarepta Therapeutics Inc options that overlap earnings dates are often higher than other days of the year. In other words, the premiums you pay to own Sarepta Therapeutics Inc options are typically higher during that period. In particular, they are frequently higher immediately before earnings and on the day they’re announced.

This makes sense considering that prices are often more volatile on earnings dates for Sarepta Therapeutics Inc. That potential volatility is a key factor that affects the premium cost of owning options.

Once the earnings announcement is done and the anticipated price volatility has gone down, the extrinsic values of Sarepta Therapeutics Inc options often go down. This is sometimes referred to as volatility crush.

Learning More Sarepta Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Sarepta Therapeutics Inc earnings or anything else related to the stock market.